| Literature DB >> 3893420 |
Abstract
The 1,4-alpha-glucosidase inhibitor. Acarbose, when injected intraperitoneally disturbs liver lysosome metabolism, causing distinct and persistent inhibition of the enzymes and acute disturbances of lysosomal glycogen metabolism. A feedback control mechanism appears to operate, affecting cytosolic carbohydrate metabolism. A model is suggested for the adult form of lysosomal storage disease. The biochemical effects closely resemble those occurring in glycogenosis type II (Pompe's disease), and these have been confirmed by electron microscopy.Entities:
Mesh:
Substances:
Year: 1985 PMID: 3893420 PMCID: PMC1144989 DOI: 10.1042/bj2280319
Source DB: PubMed Journal: Biochem J ISSN: 0264-6021 Impact factor: 3.857